Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
Comparing different approaches to Covid-19 containment | 56 comments (56 topical, editorial, 0 hidden)
Re: Funny, because it's true UPDATE! (none / 1)
US government will decide where remdesivir goes amid coronavirus outbreak, drugmaker says
remdesivir was found to shorten the duration of illness [by 30%!] in patients with severe COVID-19, but it had no statistically significant effect on whether patients died.
[...]
Gilead has donated 1.5 million vials of the drug, O'Day said, which amounts to between 100,000 and 200,000 treatment courses, depending on how long patients take it.

"This donation will be made available to patients here in America in the United States and across the world, as other regulatory decisions are taken for those countries," he said.
[...]
In a press release on Friday, Gilead said its goal is to produce at least 500,000 treatment courses by October and more than a million by December.

The FDA-authorized drug is infused through an IV, and its use is limited to hospitalized patients with severe disease. But O'Day said Gilead is looking at other formulations of remdesivir too -- including an inhaled version that could be given outside of the hospital.

by Cat on Mon May 4th, 2020 at 01:47:40 AM EST
[ Parent ]

Others have rated this comment as follows:

Frank Schnittger 4

Comparing different approaches to Covid-19 containment | 56 comments (56 topical, 0 editorial, 0 hidden)
Display: